hypericin and pd 98059

hypericin has been researched along with pd 98059 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Romerio, F; Zella, D	1

Other Studies

1 other study(ies) available for hypericin and pd 98059

Article	Year
MEK and ERK inhibitors enhance the anti-proliferative effect of interferon-alpha2b. FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2002, Volume: 16, Issue:12 Topics: Anthracenes; CD4-Positive T-Lymphocytes; Cell Cycle; Cell Division; Drug Synergism; Enzyme Inhibitors; Flavonoids; Humans; Interferon alpha-2; Interferon-alpha; Mitogen-Activated Protein Kinase Kinases; Mitogen-Activated Protein Kinases; Perylene; Proto-Oncogene Proteins c-raf; ras Proteins; Recombinant Proteins; Signal Transduction; Time Factors	2002

Article

Year

MEK and ERK inhibitors enhance the anti-proliferative effect of interferon-alpha2b.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2002, Volume: 16, Issue:12

Topics: Anthracenes; CD4-Positive T-Lymphocytes; Cell Cycle; Cell Division; Drug Synergism; Enzyme Inhibitors; Flavonoids; Humans; Interferon alpha-2; Interferon-alpha; Mitogen-Activated Protein Kinase Kinases; Mitogen-Activated Protein Kinases; Perylene; Proto-Oncogene Proteins c-raf; ras Proteins; Recombinant Proteins; Signal Transduction; Time Factors

2002